INBX - Inhibrx, Inc.
NASDAQ
->
Healthcare
->
Biotechnology
La Jolla,
United States
Type: Equity
INBX price evolution
INBX
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $226.86 | $252.48 | $277.92 | |
| Short term investments | ||||
| Net receivables | $1.13 | $1.39 | $0.3 | $0.78 |
| Inventory | ||||
| Total current assets | $207.45 | $242.06 | $14.18 | $295.36 |
| Long term investments | ||||
| Property, plant & equipment | $8.4 | $9.62 | $9.45 | $9.37 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $16.36 | $14.04 | $12.54 | |
| Total investments | ||||
| Total assets | $222.56 | $258.42 | $28.22 | $307.89 |
| Current liabilities | ||||
| Accounts payable | $12.37 | $13.02 | $12.37 | $10.95 |
| Deferred revenue | ||||
| Short long term debt | $2.17 | $2.12 | $2.06 | |
| Total current liabilities | $44.09 | $39.05 | $38.43 | $56.31 |
| Long term debt | $0.56 | $208.08 | ||
| Total noncurrent liabilities | $0.56 | $208.08 | ||
| Total debt | $2.17 | $2.68 | $210.14 | |
| Total liabilities | $44.09 | $39.05 | $38.99 | $264.39 |
| Shareholders' equity | ||||
| Retained earnings | -$58.27 | -$14.4 | -$692.44 | -$613.73 |
| Other shareholder equity | ||||
| Total shareholder equity | $219.37 | -$10.77 | $43.5 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $277.92 | $273.87 | $131.3 | $128.66 |
| Short term investments | ||||
| Net receivables | $0.78 | $0.26 | $0.88 | $0.61 |
| Inventory | ||||
| Total current assets | $295.36 | $280.49 | $139.11 | $132.17 |
| Long term investments | ||||
| Property, plant & equipment | $9.37 | $7.22 | $9.49 | $11.32 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $12.54 | $10.38 | $11.34 | $11.57 |
| Total investments | ||||
| Total assets | $307.89 | $290.88 | $150.45 | $143.74 |
| Current liabilities | ||||
| Accounts payable | $10.95 | $8.33 | $9.13 | $13.46 |
| Deferred revenue | $0.17 | $2.14 | $3.82 | |
| Short long term debt | $2.06 | $1.86 | $1.67 | $1.5 |
| Total current liabilities | $56.31 | $27.58 | $22.45 | $31.4 |
| Long term debt | $208.08 | $202.07 | $75.5 | $35.95 |
| Total noncurrent liabilities | $208.08 | $205.24 | $75.61 | $36.87 |
| Total debt | $210.14 | $207.1 | $77.18 | $37.45 |
| Total liabilities | $264.39 | $232.82 | $98.07 | $68.27 |
| Shareholders' equity | ||||
| Retained earnings | -$613.73 | -$372.37 | -$227.15 | -$145.38 |
| Other shareholder equity | ||||
| Total shareholder equity | $43.5 | $58.06 | $52.38 | $75.47 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $0.1 | $1.63 | ||
| Cost of revenue | ||||
| Gross Profit | $0.1 | $1.63 | ||
| Operating activities | ||||
| Research & development | $67.63 | $40.43 | $82.09 | |
| Selling, general & administrative | $93.37 | $8.78 | $7.83 | |
| Total operating expenses | $46.8 | $161 | $49.21 | $89.92 |
| Operating income | -$160.9 | -$49.21 | -$88.29 | |
| Income from continuing operations | ||||
| EBIT | $1863.37 | -$49.27 | -$85.39 | |
| Income tax expense | $0 | -$0 | ||
| Interest expense | $2.89 | $5.36 | $8.22 | |
| Net income | ||||
| Net income | -$43.86 | $1858.01 | -$49.27 | -$93.6 |
| Income (for common shares) | $1858.01 | -$49.27 | -$93.6 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1.8 | $2.19 | $7.23 | $12.89 |
| Cost of revenue | ||||
| Gross Profit | $1.8 | $2.19 | $7.23 | $12.89 |
| Operating activities | ||||
| Research & development | $191.64 | $110.19 | $71.44 | $73.5 |
| Selling, general & administrative | $29.38 | $21.12 | $12.36 | $6.84 |
| Total operating expenses | $221.02 | $131.31 | $83.8 | $80.33 |
| Operating income | -$219.22 | -$129.12 | -$76.56 | -$67.44 |
| Income from continuing operations | ||||
| EBIT | -$209.52 | -$129.12 | -$76.55 | -$65.31 |
| Income tax expense | $0 | $0 | $0 | $0 |
| Interest expense | $31.84 | $16.11 | $5.22 | $10.82 |
| Net income | ||||
| Net income | -$241.36 | -$145.23 | -$81.77 | -$76.12 |
| Income (for common shares) | -$241.36 | -$145.23 | -$81.77 | -$76.12 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $1858.01 | -$49.27 | -$93.6 | |
| Operating activities | ||||
| Depreciation | $0.95 | $0.82 | $0.75 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $46.17 | $5.04 | $6.43 | |
| Total cash flows from operations | -$57.36 | -$40.31 | -$56.82 | |
| Investing activities | ||||
| Capital expenditures | -$1.22 | -$1.12 | -$3.44 | |
| Investments | ||||
| Total cash flows from investing | -$2.58 | -$1.22 | -$1.12 | -$3.44 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $32.95 | $0.86 | ||
| Net borrowings | ||||
| Total cash flows from financing | $71.68 | $32.95 | $41.43 | $0.86 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$81.59 | -$25.62 | -$59.4 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$241.36 | -$145.23 | -$81.77 | -$76.12 |
| Operating activities | ||||
| Depreciation | $2.96 | $2.85 | $2.69 | $2.39 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $24.85 | $20.45 | $15.05 | $5.02 |
| Total cash flows from operations | -$193.31 | -$115.3 | -$80.32 | -$47.97 |
| Investing activities | ||||
| Capital expenditures | -$4.59 | -$0.69 | -$0.81 | -$1.36 |
| Investments | ||||
| Total cash flows from investing | -$4.59 | -$0.69 | -$0.81 | -$1.36 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $201.96 | $130.13 | $44.16 | $136.88 |
| Net borrowings | $128.81 | $39.99 | $40.57 | |
| Total cash flows from financing | $201.96 | $258.55 | $83.77 | $166.46 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $4.06 | $142.56 | $2.64 | $117.12 |
News
Fundamentals
| Market cap | $181.82M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 14.48M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $1.67B |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | 0.11 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | $115.45 |
|---|---|
| ROA | 818.15% |
| ROE | N/A |
| Debt/Equity | 6.08 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 4.70 |
| Quick ratio | N/A |